Approvals/CIMA-AEMPS/SOLIFENACINA/TAMSULOSINA ARISTO 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG

Approved

STANDARD

SOLIFENACINA/TAMSULOSINA ARISTO 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG

Aristo Pharma Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: df64190196a688ab
Drug Cima Aemps Name: SOLIFENACINA/TAMSULOSINA ARISTO 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG
Register Number: 88689
Holder Company Name: Aristo Pharma Gmbh
Marketing Company Name: Aristo Pharma Iberia S.L.
Holder Company Detail Path: /organization/aristo-pharma-gmbh
Authorization Date: 2023-02-24
Dosage Form: COMPRIMIDO DE LIBERACIÓN MODIFICADA
Dose: 6 mg/0,4 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Aristo Pharma Gmbh
Company Detail Path: /organization/aristo-pharma-gmbh

TAMSULOSINA HIDROCLORURO

0,4 mg

SOLIFENACINA SUCCINATO

6 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 24, 2023

Approval ID

df64190196a688ab

Type

Standard